A new approach to classifying malnutrition in the hemodialysis patient

Journal of Renal Nutrition

Volumn 12, Issue 4, 2002, Pages 248-255

  O'Keefe, Aura ^a   Daigle, Nancy W ^b  

^a San Diego Dialysis National City   (United States)

^b San Diego Dialysis Chula Vista South   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010180     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/jren.2002.35322     Document Type: Article

References (48)

1. Stenvinkel, P, Heimburger, O, Lindholm, B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis. Nephrol Dial Transplant 15 (2000), 953–960.
2. Stenvinkel, P, Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19 (2001), 143–151.
3. Kaysen, GA, The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12 (2001), 1549–1557.
4. Kaysen, GA, Chertow, GM, Adhikarla, R, et al. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60 (2001), 333–340.
5. Bistrian, B, Interaction between nutrition and inflammation in end-stage renal disease. Blood Purif 18 (2000), 333–336.
6. Kaysen, GA, Malnutrition and the acute-phase reaction in dialysis patients—how to measure and how to distinguish. Nephrol Dial Transplant 15 (2000), 1521–1524.
7. Kaysen, GA, C-reactive protein: A story half told. Semin Dial 13 (2000), 143–146.
8. Kaysen, GA, Interpretation of plasma protein measurements in end-stage renal disease. Blood Purif 18 (2000), 337–342.
9. Arici, M, Walls, J, End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney Int 59 (2001), 407–414.
10. Yeun, JY, Kaysen, GA, Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 32:suppl 4 (1998), S-118–S-125.
11. Yeun, JY, Clinical utility of C-reactive protein measurements. Semin Dial 13 (2000), 56–57.
12. Bergstrom, J, Lindholm, B, Lacson, E, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?. Semin Dial 13 (2000), 163–164.
13. Stenvinkel, P, Heimburger, O, Paultre, F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 (1999), 1899–1911.
14. Drueke, TB, Khoa, N, Massy, ZA, et al. Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. Kidney Int 59:suppl (2001), S-114–S-119.
15. Bistrian, B, Carey, LA, Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients. Nephrol Nurs J 27 (2000), 616–621.
16. Jern, NA, VanBeber, AD, Gorman, MA, et al. The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients. J Renal Nutr 10 (2000), 148–153.
17. Balzer, C, Nutrition supplementation in end-stage renal disease: Are we being too conservative?. Dial Transplant 30 (2001), 387–390.
18. Beto, JA, Which diet for which renal failure: Making sense of the options. J Am Diet Assoc 95 (1995), 898–903.
19. Buccianti, G, Bamonti, CF, Patrosso, C, et al. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B (12) in uraemic patients on maintenance haemodialysis. Am J Nephrol 21 (2001), 294–299.
20. Crawford, JF, Rosenthal, AF, Spears, C, et al. Normalization of homocysteine in dialysis patients by directed repletion, with apparent reduction of access thrombosis. Dial Transplant 30 (2001), 512–514 516-521.
21. Descombes, E, Hanck, AB, Fellay, G, Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 43 (1993), 1319–1328.
22. Dierkes, J, Domrose, U, Bosselmann, KP, et al. Homocysteine lowering effect of different multivitamin preparations in patients with end-stage renal disease. J Renal Nutr 11 (2001), 67–72.
23. Descombes, E, Boulat, O, Perriard, F, et al. Water soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation. Artif Organs 24 (2000), 773–778.
24. Descombes, E, Boulat, O, Bersier, LF, et al. Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease. Nephrol Dial Transplant 16 (2001), 585–589.
25. Gonenc, A, Atak, Y, Orman, MN, et al. Lipid perioxidation and antioxidant systems in hemodialysis patients. Dial Transplant 31 (2002), 88–91 94-96.
26. Hegbrant, J, Bengtsson, UH, Vitamin C and E as antioxidants in hemodialysis patients. Int J Artif Organs 22 (1999), 69–73.
27. 12 and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Kidney Int 59 (2001), 1103–1109.
28. Nakayama, H, Akiyama, S, Inagaki, M, et al. Dehydroascorbic acid and oxidative stress in hemodialysis patients. Nephrol Dial Transplant 16 (2001), 574–579.
29. Sepe, V, Ottone, S, Patrucco, G, et al. Effectiveness of oral supplements of folates, vitamin B12 and B6 in hemodialysis patients. Preliminary results after 5 months of follow-up. Minerva Urol Nefrol 53 (2001), 57–59.
30. Tremblay, R, Bonnardeaux, A, Geadah, D, et al. Hyperhomocysteinemia in hemodialysis patients: Effect of 12-month supplementation with hydrosoluble vitamins. Kidney Int 58 (2000), 851–858.
31. Boaz, M, Smetana, S, Weinstein, T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomized placebo-controlled trial. Lancet North Am Ed 356 (2000), 1213–1218.
32. Islam, KN, O'Byrne, D, Devaraj, S, et al. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 150 (2000), 217–224.
33. Jackson, P, Loughrey, CM, Lightbody, JH, et al. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41 (1995), 1135–1138.
34. Maccarrone, M, Meloni, C, Manca-di-Villahermosa, S, et al. Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am J Kidney Dis 37 (2001), 964–969.
35. Morena, M, Cristol, J-P, Canaud, B, Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance?. Blood Purif 18 (2000), 191–199.
36. Roob, JM, Khoschsorur, G, Tiran, A, et al. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 11 (2000), 539–549.
37. Weiss, M, Vitamin E for dialysis patients. Semin Dial 14 (2000), 71–72.
38. Peck, LW, Role of omega-3 (n-3) fatty acids in treatment of chronic renal failure. Renal Nutrition Forum 19 (2000), 6-8–6-12, 14.
39. Ando, M, Sanaka, T, Nihei, H, Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivi perioxidation of LDL in dialysis patients. J Am Soc Nephrol 10 (1999), 2177–2184.
40. Khajehdehi, P, Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Renal Nutr 10 (2000), 191–195.
41. Donnelly, SM, Ali, MA, Churchill, DN, Effect of n-3 fatty acids from fish oil on homeostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol 2 (1992), 1634–1639.
42. Rolf, N, Tenschert, W, Lison, AE, Results of a long-term administration of omega-3 fatty acids in haemodialysis patients with dyslipoproteinaemia. Nephrol Dial Transplant 5 (1990), 797–801.
43. Khajehdehi, P, Effect of vitamins on the lipid profile of patients on regular dialysis. Scand J Urol Nephrol 34 (2000), 62–66.
44. Galli, F, Varga, Z, Balla, J, et al. Vitamin E, lipid profile, and perioxidation in hemodialysis patients. Kidney Int 59:suppl 78 (2001), S-148–S-154.
45. Handelman, G, Evaluation of oxidant stress in dialysis patients. Blood Purif 18 (2000), 343–349.
46. Morena, M, Cristol, JP, Bosc, JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 17 (2002), 422–427.
47. Stenvinkel, P, Andersson, P, Wang, T, et al. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure?. J Intern Med 246 (1999), 503–507.
48. de Cavanagh, EMV, Ferder, L, Carrasquedo, F, et al. Higher levels of anti-oxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kidney Dis 34 (1999), 445–455.